Vactosertib
Search results
Scope
Date
~
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
1
Latest News
- 1 NPS-backed new prime office struggles with poor demand
- 2 Affinity-backed SSG.COM offers first voluntary redundancy
- 3 Lotte to cut basic chemicals in portfolios for profitability
- 4 Young rich Koreans: Financially literate, self-directing
- 5 LG Elec logs record Q2 profit on home appliances, car parts